Drawing for STOP-AKI

USPTO serial 79168870

STOP-AKI

Reviewed by CopyMark Law Group

Reg. 4911567Status 404
Filing date
Status date
Registration date
Mar 8, 2016
Examiner
WEIGLE, KATHERINE CONNOLLY
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STOP-AKI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James C. Watson

James C. Watson TraskBritt, P.C.230 South 500 East, #300Salt Lake City, UT 84102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Protein arrays for use in recombinant DNA scientific and medical research other than for medical diagnostic use; recombinant nucleic acid for laboratory use; diagnostic preparations and reagents for scientific or research purposes in the field of inflammatory diseases and kidney diseases, other than for medical use; diagnostic sets consisting of diagnostic preparations with test receptors and reagents for testing of selected bacteria for scientific or research use; chemicals for use in the production of medicines for the treatment of inflammatory diseases and kidney diseases ]SECTION 71 - CANCELLED—
005[ Pharmaceutical preparations in the field of inflammatory diseases and kidney diseases; diagnostic preparations in the field of inflammatory diseases and kidney diseases for medical use; enzyme preparations in the field of inflammatory diseases and kidney diseases for medical use; medicines for human purposes for the treatment of inflammatory diseases and kidney diseases ]SECTION 71 - CANCELLED—
042Scientific research, technological research and industrial research; development of technologies, diagnostics, medicines and dietary supplements; biotechnology research in the field of enzymatic synthesis; product testing, authentication and quality control for others; performing clinical trials for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research related to medicines, all the aforementioned related to the treatment of inflammatory diseases and kidney diseasesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 26, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 8, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jul 3, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 19, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 19, 2023INPCINVALIDATION PROCESSED—
Apr 5, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 5, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 5, 202271.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Aug 2, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 8, 2022ES71TEAS SECTION 71 RECEIVED—
Mar 8, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 14, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 9, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 21, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 21, 2016FIMPFINAL DISPOSITION PROCESSED—
Jun 8, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 8, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 4, 2016GPNXNOTIFICATION PROCESSED BY IB—
Dec 22, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 22, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 16, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 2, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 23, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 16, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 16, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Oct 16, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 16, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 16, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 15, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2015RFNTREFUSAL PROCESSED BY IB—
Jul 31, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 28, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 28, 2015RFRRREFUSAL PROCESSED BY MPU—
Jul 28, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 27, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2015DOCKASSIGNED TO EXAMINER—
Jul 27, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 22, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 16, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance